ACCESS Newswire

The newsfeed available here is provided by our content partner ACCESS Newswire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public.

The NewsWire Hub ("X-Billboard") currently comprises five of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and form a complementary information offering that covers more than three quarters of the official news sources on which editorial offices worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 63
6.467,05 S&P · 15,75 Vola-Index · 122.859,11 BTC · 1,17052 EURUSD
System-State: Number of processed items 15.757 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              

ACCESS Newswire is an important news source for private investors, investors and traders that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market players in one central location. If you want to get a quick overview, you can easily scroll through the headlines. Those who want to take a closer look at the news can use the detailed views of the info cards to directly access the respective news item and other analysis tools.

NEWS
EXPLORER
CA0717341071
State: 13.08.2025 | 11PM
Do you already know our new terminal view? Click here.
FIGI: BBG000DC8RC7
BHC
Bausch Health Companies Inc
GICS: 35202010 · Sector: Life Sciences · Sub-Sector: -
NAME
Bausch Health Companies Inc
ISIN
CA0717341071
TICKER
BHC
MIC
XTSX
REUTERS
BHC.TO
BLOOMBERG
BHC CN
Thu, 07.08.2025       Bausch Health
CA0717341071

For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS Newswire / August 7, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients of its 2025 Salix Gastroi...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Wed, 30.07.2025       Bausch Health
CA0717341071

Second Quarter Consolidated Revenues of $2.53 billion, up 5% on a Reported basis and 4% on an Organic (non-GAAP)1 basis over the prior year periodGAAP Net Income Attributable to Bausch Health Companies of $148 million and GAAP Net Income of $128 millionConsolidated Adjusted EBITDA Attributable to Bausch Health Companies (non-GAAP)1 of $842 million,...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Tue, 29.07.2025       Bausch Health
CA0717341071

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitisProposed acquisition strengthens Bausch Health's commitment to hepatology and patients suffering with liver disease complications glob...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Mon, 28.07.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / July 28, 2025 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company") today announced that its subsidiary, Bausch Health Americas, Inc., has issued an irrevocable notice of redemption pursuant to which it will redeem approximately $602 million of aggregate principal a...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Thu, 24.07.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective July 22, 2025. The appointments increase the size of the Board from ten to twelve members.Michael Goet...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Thu, 10.07.2025       Bausch Health
CA0717341071

This press release updates the headline of the previously posted release LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment ...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Thu, 10.07.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Steven Lee as Senior Vice President, Controller and Chief Accounting Officer, effective Monday, July 14.Steven brings extensive experience in financial transformation, merge...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Wed, 09.07.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgaris,1 is now available to beneficiaries of the public drug pl...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Mon, 07.07.2025       Bausch Health
CA0717341071

Focused on highlighting real patient experiences, Salix continues to lead the charge in educating and advocating for the hepatic encephalopathy community LAVAL, QC / ACCESS Newswire / July 7, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced its...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Wed, 02.07.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be ...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Wed, 14.05.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual Meeting") held on May 13, 2025. The detailed results of the vote for the election of directors are set out below:Name For Withheld Brok...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Tue, 06.05.2025       Bausch Health
CA0717341071

New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced ...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Wed, 30.04.2025       Bausch Health
CA0717341071

First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year periodGAAP Net Loss Attributable to Bausch Health Companies of $58 million and GAAP Net Loss of $86 millionConsolidated Adjusted EBITDA Attributable to Bausch Health Companies (non-GAAP) 1 of $661 million, in l...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Tue, 29.04.2025       Bausch Health
CA0717341071

A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its aesthetic business, Solta Medical, announced today that Health Canada has granted med...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Fri, 25.04.2025       Bausch Health
CA0717341071

The next generation of skin resurfacing technology will debut at the ASLMS 2025 Conference LAVAL, QC / ACCESS Newswire / April 25, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its aesthetics business, Solta Medical, announced today Fraxel FTX™ will launch at the American Society fo...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Tue, 22.04.2025       Bausch Health
CA0717341071

Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Shares LAVAL, QC / ACCESS Newswire / April 22, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX: BHC) (the "Company" or "Bausch Health") today announced that it has filed a supplem...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Thu, 17.04.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today announced the U.S. District Court for the District of Columbia in the matter of Norwich Pharmaceuticals, Inc. v. Kennedy, et al. ...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Mon, 14.04.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approved the adoption of a shareholder rights plan (the "SRP") pursuant to a shareholder rights plan agreement entere...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Thu, 10.04.2025       Bausch Health
CA0717341071

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)and its dermatology business, Ortho Dermatologics, today announced the 2025 ASPIRE HIGHER Scholarship Progr...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Wed, 09.04.2025       Bausch Health
CA0717341071

LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Canadian public drug plan coverage for PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) g...
Read More
Bausch Health
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Onco-Innovations
Onco-Innovations Announces Closing of Private Placement
© ACCESSWIRE
Avino Silver & Gold Mines
Avino Announces Q2 2025 Financial Results
© ACCESSWIRE
Dermata Therapeutics Inc
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
© ACCESSWIRE
Air T Inc
Air T, Inc. Reports First Quarter Fiscal 2026 Results
© ACCESSWIRE
Generation Income Properties
Generation Income Properties Successfully Exercises Option to Extend Preferred Equity Maturity of JV Subsidiary by Complying with Underwriting Covenants
© ACCESSWIRE
GEE Group
GEE Group Announces Results for the Fiscal 2025 Third Quarter and YTD
© ACCESSWIRE
Dolphin Digital Media
Dolphin Announces Record Q2 Revenue of $14.1 Million, up 23% YoY; Deepens Investment in Women's Sports and Affiliate Marketing
© ACCESSWIRE
Loop Industries
Loop Industries' India Joint Venture Reaches Agreement to Acquire Strategic Site in Gujarat, India, for Infinite Loop Manufacturing Facility
© ACCESSWIRE
AsiaFIN
AsiaFIN Holdings Announces Second Quarter 2025 Financial Results
© ACCESSWIRE
US00902F1057
Ainos Reports Second Quarter 2025 Financial Results
© ACCESSWIRE
xxx
Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates
© ACCESSWIRE
MultiSensor AI
MultiSensor AI Announces Second Quarter 2025 Results
© ACCESSWIRE
Tenon Medical Inc
Tenon Medical Reports Second Quarter 2025 Financial Results
© ACCESSWIRE
Vox Royalty
Vox Royalty Announces Q2 2025 Financial Results and Declares Quarterly Dividend
© ACCESSWIRE
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
© ACCESSWIRE
Electrovaya
Electrovaya Reports Q3 Fiscal Year 2025 Results
© ACCESSWIRE
xxx
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
© ACCESSWIRE
US8890682011
APOZ is Gaining Momentum Fast on the Global Stage
© ACCESSWIRE
Arras Minerals
Arras Minerals Drills 440 Meters Grading 0.49% CuEq Including 252 Meters Grading 0.52% CuEq on Berezski Central Target
© ACCESSWIRE
Healthy Extracts
Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50%
© ACCESSWIRE
Silver Scott Mines
Ashley Jelks, Founder of High Priestess Life, Joins Peachhim.com and Eggplanther.com as Expert Contributor; High Priestess Products to Be Featured Across Both Platforms
© ACCESSWIRE
US8890682011
Another Global Company is Committed to Relocate into APOZ from Asia
© ACCESSWIRE
BioLargo
BioLargo Reports Q2 2025 Operating and Financial Results
© ACCESSWIRE
SMX
SMX Bridges the UN Plastics Treaty Divide with Verified Circularity (NASDAQ: SMX)
© ACCESSWIRE
Informa
NBJ Summit Unites Leaders to Navigate Market Disruption and Transformation
© ACCESSWIRE

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the international investor community, we would like to thank AccessWire for providing the news and data feeds

 

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S